U.S., May 27 -- ClinicalTrials.gov registry received information related to the study (NCT07606677) titled 'Peripheral Blood CyTOF Immune Model for Cervical Lesion Detection in HPV16/18+ Women' on May 06.

Brief Summary: This prospective, multicenter cohort study will recruit eligible HPV16/18-positive women from three tertiary hospitals in China. Peripheral blood samples and clinical data (cytology, HPV genotyping, colposcopy-directed biopsy) will be collected, followed by standardized mass cytometry (CyTOF) to develop and evaluate an immune model across cervical lesion grades.

Study Start Date: May 15

Study Type: OBSERVATIONAL

Condition: CIN 2/3 Cervical Cancer (Early Detection)

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Women'...